Related Experiment Video
Updated: Jul 9, 2026

Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
The pharmaceutical industry as an informant.
1Medicines Policy Unit, Department of Pharmacology and Clinical Pharmacology, St George's Hospital Medical School, SW17 0RE, London, UK. jcollier@sghms.ac.uk
The pharmaceutical industry prioritizes medical information over drug production, influencing healthcare practices. This commercially driven information, often confidential, can sometimes conflict with patient and societal interests.
Area of Science:
- Pharmaceutical industry
- Medical information management
- Healthcare economics
Background:
- The pharmaceutical sector invests heavily in generating, collecting, and distributing medical information, often exceeding resources allocated to drug manufacturing.
- This medical information serves critical functions, including aiding drug development, meeting regulatory and patent requirements, supporting sales, and informing healthcare professionals and patients.
Purpose of the Study:
- To analyze the significant resource allocation towards medical information within the pharmaceutical industry.
- To examine the dual role of this information as both a developmental resource and a commercial asset.
- To evaluate the impact of commercially driven information dissemination on clinical practice and patient welfare.
Main Methods:
- Qualitative analysis of industry practices regarding medical information.
- Review of regulatory and intellectual property frameworks governing pharmaceutical data.
- Assessment of the influence of transnational pharmaceutical companies on healthcare.
Main Results:
- Pharmaceutical companies dedicate substantial resources to medical information management, often surpassing drug production investments.
- Commercial interests heavily influence the creation and dissemination of medical information, which is frequently confidential and proprietary.
- The management and dissemination of pharmaceutical information can impact clinical practice, with potential conflicts between commercial goals and public health interests.
Conclusions:
- The pharmaceutical industry's focus on information management is a critical aspect of its operations, driven by commercial and regulatory imperatives.
- Confidentiality and commercial interests in pharmaceutical information can create challenges in ensuring transparency and optimal patient care.
- Further examination is needed to balance the commercial value of pharmaceutical information with the need for accessible, unbiased data to safeguard patient and societal well-being.
Related Concept Videos
Drug Nomenclature
Drug Regulation
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Pharmaceutical Equivalents
Pharmaceutical Poisoning: Potential Scenarios

